Home Leaderna

Leaderna

In operation
Series A+
Nucleic Acid Drug Developer
Basic
Enterprise Profile

Basic Information

Leaderna focuses on the field of oligonucleotide new drugs, and through independent and collaborative development, it advances new drugs targeting metabolism, cardiovascular and cerebrovascular diseases, chronic inflammation, and tumor immunology, rapidly moving oligonucleotide new drugs into clinical and commercialization stages.
Leaderna Therapeutics Ltd.
Sichuan,China
15~50 people
July 13, 2022
--
--

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Nucleic Acid Technology
Concept
Tumor Cardiovascular Disease Endocrine System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs Small Nucleic Acid Drugs